On July 22, 2026, Emergent BioSolutions Inc. (NYSE: EBS) announced plans to hold a conference call on August 5, 2026, at 5:00 p.m. EST to review the financial performance for the second quarter of 2026. This call will offer insights into the company's revenues, profits, and overall financial outlook for investors and stakeholders.
